Upadacitinib 99% white powder 1310726-60-3 Senwayer

Upadacitinib is a slow release tablet used to treat certain autoimmune disorders. It was first approved by the FDA in 2019 for rheumatoid arthritis and since then has been approved for types of psoriatic arthritis, eczema and ulcerative colitis.

It is from a class of medicines called Janus kinase inhibitors (JAKi), they block the action of enzymes (Janus kinases) which are involved in inflammation. Blocking the Janus kinases reduces inflammation and helps bring symptoms under control.

Wuhan senwayer century chemical Co.,Ltd located in the predominant WuHan City where is a traffic hinge of China,specilize in producing and developing pharmaceutical & its intermediates, Pesticide Intermediate, food additive, Plant extracts,and in distributing the products of our own company and affiliated enterprises.
We have set up R&D center, quality inspection center and manufacturing site in Wuhan, Jiangsu and others places.
Our company has professional staff who deal with chemical R&D and scientific management, and holds several sets of analyzing instruments with high efficiency and high sensitivity, such as HPLC, GC and Spectrophotometer. Meanwhile, we possess of complete Q.A. and Q.C. system, supply chemical products with good quality and custom-tailored products according to our clients' requirement.
We have professional sales team, focus on quality and service, and we have achieved excellent performance over the years. Our company is committed to the development of international market , our products are mainly exported to many countries and regions, such as Europe, America, South-east Asia, the Middle East and Africa etc.
With our constant efforts and good service, We sincerely hope to establish long-term cooperation and common development with our customers.
If you are interested, pls contact me freely!